Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Prevalence Show Comments PDF Print E-mail
  

KIDNEY CONDITIONS
(infection, kidney stones, cancer, missing kidney, other)

Prevalence (1996): 2.553 million conditions (in the civilian noninstitutionalized population)1

POLYCYSTIC KIDNEY DISEASE

Prevalence: About 600,000 people1

HEMOLYTIC UREMIC SYNDROME, POSTDIARREAL

Incidence (first 4 years of reporting)
1999: 181 cases in 26 States2
1998: 90 cases in 17 States3
1997: 93 cases in 20 States3
1996: 104 cases in 18 States3

END-STAGE RENAL DISEASE (ESRD)

Period prevalence (1999): 424,179 people4

Resulting from these primary diseases:
Diabetes: 150,404
Hypertension: 100,169
Glomerulonephritis: 62,119

Incidence (new beneficiaries of treatment, 1999): 89,252 people5

Resulting from these primary diseases:
Diabetes: 38,160
Hypertension: 23,133
Glomerulonephritis: 8,038
Cystic kidney: 2,096
All other: 17,825

ESRD deaths in treated patients (1999): 66,964 people4

Amount spent (public and private, 1999): $17.87 billion4

ESRD treatment:
Use of dialysis (1999): 243,320 people4
In-center hemodialysis: 212,601
Home hemodialysis: 3,148
Peritoneal dialysis: 22,797
CAPD*: 13,406
CCPD: 9,178
Other PD: 213
Uncertain dialysis: 4,774

*CAPD=continuous ambulatory peritoneal dialysis;
CCPD=continuous cycler-assisted peritoneal dialysis;
PD=peritoneal dialysis

Number of kidney transplants
(by year, reported in annual facility survey)4:
1999: 13,483
1998: 13,272
1997: 12,427
1988: 8,932

Number of kidney transplants
(by type, 1999, reported in annual facility survey)4:
From cadaver: 8,839
From living related donor: 3,583
From living unrelated donor: 1,061

People awaiting transplants
(November 2, 2001)5:
Kidney (only): 50,305
Kidney and pancreas: 2,486

Dialysis survival
(probability of patients surviving, from day 91 of ESRD, unadjusted)4:
1 year (1998-1999): 78.4
2 years (1997-1999): 62.8
5 years (1994-1999): 31.3
10 years (1989-1999): 8.7

Patient survival following cadaver transplant
(probability of recipients surviving, from day 1 of transplantation, unadjusted)4:
1 year (1998-1999): 94.9
2 years (1997-1999): 91.5
5 years (1994-1999): 80.4
10 years (1989-1999): 59.5

Patient survival following living-donor transplant
(probability of recipients surviving, from day 1 of transplantation, unadjusted)4:
1 year (1998-1999): 98.0
2 years (1997-1999): 96.6
5 years (1994-1999): 89.8
10 years (1989-1999): 78.8

Graft survival following cadaver transplant
(probability of transplanted kidney surviving, from day 1 of transplantation, unadjusted)4:
1 year (1998-1999): 88.8
2 years (1997-1999): 83.1
5 years (1994-1999): 58.1
10 years (1989-1999): 35.4

Graft survival following living-donor transplant
(probability of transplanted kidney surviving, from day 1 of transplantation, unadjusted)4:
1 year (1998-1999): 94.1
2 years (1997-1999): 89.7
5 years (1994-1999): 71.8
10 years (1989-1999): 54.5

 


Sources:

  1. Grantham JJ, Nair V, Winklhofer F. Cystic disease of the kidney. In: Brenner BM, ed., Brenner & Rector's The Kidney. Vol. 2. 6th ed. Philadelphia: WB Saunders Company; 2000: 1699-1730.
  2. Summary of notifiable diseases, United States, 1999. Morbidity and Mortality Weekly Report (MMWR). 2001;48(53):1-104.
  3. Hemolytic uremic syndrome, postdiarrheal. MMWR. 1999;47(53):viii-ix.
  4. U.S. Renal Data System. USRDS 2001 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), DHHS; 2001. Available at www.usrds.org. Accessed November 21, 2001.
  5. United Network for Organ Sharing. Available at www.unos.org. Accessed November 2, 2001. For updates, call (804) 330-8576 or fax (804) 323-3794.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Featured Conference

Working with Industry

Case Studies
Sponsorship Opportunities

Adrenal &
Retroperitoneum
Sponsored By